P
Paul A. Rota
Researcher at Centers for Disease Control and Prevention
Publications - 276
Citations - 26506
Paul A. Rota is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Measles & Measles virus. The author has an hindex of 76, co-authored 267 publications receiving 23802 citations. Previous affiliations of Paul A. Rota include World Health Organization & National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Evolutionary genetics of genotype H1 measles viruses in China from 1993 to 2012
Songtao Xu,Yan Zhang,Pierre Rivailler,Huiling Wang,Yixin Ji,Zhu Zhen,Naiying Mao,Chongshan Li,William J. Bellini,Wenbo Xu,Paul A. Rota +10 more
TL;DR: The results suggest that detailed evolutionary analyses should facilitate the documentation of eventual measles elimination in China, and the molecular approaches used in this study can be applied in other countries approaching measles elimination.
Journal ArticleDOI
Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA
TL;DR: The antigen capture ELISA developed is potentially affordable tool to provide rapid detection and differentiation between the henipaviruses.
Journal ArticleDOI
New Measles Genotype, Uganda
Apollo Muwonge,Miriam Nanyunja,Paul A. Rota,Josephine Bwogi,Luis Lowe,Stephanie L. Liffick,William J. Bellini,Sempala Sylvester +7 more
TL;DR: New measles virus genotype will increase epidemiologic and virologic surveillance in Africa and improve surveillance of measles cases in Africa.
Journal ArticleDOI
Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells
TL;DR: A preexisting component of MV particles that leads to strain‐specific differences in the activation of NF‐κB and the induction of ICAM‐1 gene expression is suggested.
JournalDOI
Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.
TL;DR: A number of other modulators of calcium flux, including calcium channel and calmodulin antagonists also exhibited potent antiviral activity in vitro providing a broad range of potential therapeutic options for the treatment of henipavirus infections.